Insulin (Fasting) Blood Test

What Does This Test Measure?

Insulin is a hormone produced by pancreatic beta cells that enables cells to take up glucose from the blood. Fasting insulin, together with fasting glucose, is used to assess insulin resistance (HOMA-IR) and beta-cell function. Insulin levels are most informative when interpreted alongside glucose.

Why Your Doctor Ordered This Test

Doctors order a fasting insulin test when they suspect insulin resistance, the body’s inability to respond properly to insulin, forcing the pancreas to secrete higher amounts to maintain normal blood glucose. This is a central feature of metabolic syndrome, a cluster of conditions (abdominal obesity, high triglycerides, low HDL, hypertension, and elevated fasting glucose) that dramatically raises cardiovascular and type 2 diabetes risk. The test is also used in the workup of polycystic ovary syndrome (PCOS), where insulin resistance drives ovarian androgen production, contributing to irregular cycles and infertility. In individuals with acanthosis nigricans (dark, velvety skin patches on the neck, armpits, or groin), elevated fasting insulin often confirms underlying hyperinsulinemia. Additionally, endocrinologists order fasting insulin to evaluate patients with unexplained hypoglycemia: very high insulin levels in the setting of low blood sugar raise suspicion for an insulinoma, a rare insulin-secreting tumor.

Beyond diagnosis, the test guides therapy. For patients with prediabetes or early type 2 diabetes, measuring fasting insulin before and after lifestyle interventions or metformin therapy helps gauge improvement in insulin sensitivity. In type 1 diabetes, a low or absent insulin level alongside high glucose supports the diagnosis of autoimmune beta-cell destruction, and measuring insulin helps differentiate from type 2 diabetes in ambiguous cases. The test is also essential for calculating HOMA-IR (Homeostatic Model Assessment of Insulin Resistance), a validated index that combines fasting insulin and glucose to quantify insulin resistance. Serial measurements can monitor the progression from insulin resistance to beta-cell decompensation, helping clinicians decide when to intensify treatment.

What High Insulin Means

High fasting insulin with normal/high glucose indicates insulin resistance; the pancreas is producing more insulin to overcome reduced tissue sensitivity. This is the hallmark of metabolic syndrome and prediabetes, preceding the rise in glucose. Causes: obesity (especially visceral), sedentary lifestyle, high-carbohydrate diet, PCOS, Cushing syndrome, acromegaly, and certain medications (corticosteroids, some antipsychotics). Very high insulin with low glucose suggests insulinoma (rare tumor).

What Low Insulin Means

Low fasting insulin with high glucose: type 1 diabetes (autoimmune beta-cell destruction), advanced type 2 diabetes (beta-cell exhaustion), or pancreatitis. Low insulin with low glucose: Addison disease, severe liver disease, prolonged fasting. Low insulin with normal glucose in a lean, active person is normal.

How to Prepare and What Affects the Result

Fasting insulin requires an 8- to 12-hour fast; water is permitted, but all food, coffee, and calorie-containing beverages must be avoided. Ideally, the blood draw should occur in the morning, as insulin exhibits diurnal variation, with levels often higher later in the day. Instruct patients to refrain from smoking and strenuous exercise for at least 30 minutes before the test, because acute physical activity lowers insulin and can mask underlying insulin resistance. Biotin (vitamin B7) interferes with many immunoassays that use biotin-streptavidin detection; patients taking high-dose biotin supplements (>5 mg/day) should discontinue them for at least 24–72 hours, depending on the laboratory’s protocol. Certain medications alter fasting insulin: corticosteroids, thiazide diuretics, beta-blockers, and second-generation antipsychotics can raise levels, while metformin, thiazolidinediones, and SGLT2 inhibitors lower them. Ideally, discuss with the ordering physician whether to temporarily hold these drugs, but changes must be made under supervision.

Sample handling is critical. Serum must be separated from cells within 30–60 minutes of collection and, if analysis is delayed beyond 24 hours, the sample should be frozen at -20°C or colder. Hemolysis can falsely lower insulin results because red blood cell enzymes degrade the hormone; visibly hemolyzed specimens should be rejected. Additionally, insulin levels are susceptible to proteolytic degradation at room temperature, so prompt processing is essential. Note that insulin immunoassays may cross-react with proinsulin and intermediate split products, particularly in insulinoma or renal failure, so laboratories often state the specificity of their method. If the patient has received exogenous insulin (e.g., injection or pump), the measured insulin will reflect the analogue, which may react differently depending on the assay used; in such cases, C-peptide is a more reliable marker of endogenous insulin secretion.

Common Misinterpretations

One common misconception is that a high fasting insulin in isolation equals insulin resistance. While statistically correlated, insulin resistance cannot be diagnosed by insulin alone; it requires concurrent fasting glucose to calculate HOMA-IR or at least clinical context. A non-fasting sample is a frequent error, postprandial insulin surges naturally, and measuring a random or post-meal sample can yield a result of 50–100 µIU/mL in a perfectly insulin-sensitive person, leading to unnecessary alarm. Similarly, failing to account for acute stress or recent illness can mislead; cortisol surges from infection, surgery, or even severe anxiety acutely increase insulin resistance and raise fasting insulin. Another pitfall is interpreting low insulin in lean, physically active individuals as a problem: low-normal insulin reflects high insulin sensitivity, which is physiologically desirable.

Laboratory artifacts also create misinterpretation. Hemolysis degrades insulin, causing falsely low values; clinicians may overlook this and suspect beta-cell failure. Assay interference from anti-insulin antibodies, present in many patients with type 1 diabetes or autoimmune polyendocrine syndromes, can yield spuriously high or low readings depending on whether the antibody traps or blocks the detection epitope. Some older insulin assays cross-react with proinsulin, which is elevated in insulinoma and type 2 diabetes, leading to overestimation of true insulin. When exogenous insulin (especially insulin analogues like lispro or glargine) is present, certain immunoassays under-recover the signal, while others may cross-react, making the result unreliable. For these reasons, C-peptide is often ordered alongside insulin to distinguish endogenous from exogenous hyperinsulinemia and to validate insulin results.

Frequently Asked Questions

What does a high fasting insulin level mean?

A high fasting insulin level, especially when glucose is normal or elevated, typically signals insulin resistance; the pancreas is producing extra insulin to compensate for cells that don't respond well. This is a key feature of metabolic syndrome and prediabetes. Very high insulin with low blood sugar could point to an insulinoma, a rare tumor. Obesity, a high-carbohydrate diet, and sedentary lifestyle are common drivers of elevated insulin.

Can I take medications before an insulin blood test?

Many medications affect fasting insulin results. Corticosteroids, thiazide diuretics, beta-blockers, and some antipsychotics can raise insulin levels, while metformin, thiazolidinediones, and SGLT2 inhibitors can lower them. High-dose biotin supplements (>5 mg/day) interfere with the immunoassay, producing falsely high or low results depending on the test platform. Never stop prescription drugs on your own; discuss with your doctor whether temporary withholding is safe before the test.

What is the normal fasting insulin range?

Reference ranges vary by laboratory, but typical fasting insulin is 2.6–24.9 µIU/mL. However, optimal metabolic health is reflected by levels below 10 µIU/mL. Many functional medicine practitioners further target a fasting insulin below 8 µIU/mL. Because the assay method influences results, always interpret your value using the range provided by the testing lab. Paired with fasting glucose, insulin helps compute HOMA-IR, a more precise measure of insulin sensitivity.

Why is insulin tested together with glucose?

Insulin and glucose are interdependent; measuring both simultaneously is essential because the same insulin value can mean different things depending on the glucose level. A fasting insulin of 15 µIU/mL with a glucose of 85 mg/dL suggests good compensation, while the same insulin with a glucose of 110 mg/dL indicates insulin resistance. Together they are used to calculate HOMA-IR, which quantifies resistance and beta-cell function more accurately than either marker alone.

How is insulin resistance diagnosed using this test?

Insulin resistance is not diagnosed by fasting insulin alone but by combining it with fasting glucose in the HOMA-IR formula: (fasting insulin × fasting glucose)/405. A HOMA-IR below 1.0 generally indicates normal insulin sensitivity; values above 2.0 suggest resistance, and above 2.9 in non-diabetics strongly implies insulin resistance. Some clinicians also consider a fasting insulin level consistently above 10–12 µIU/mL as supportive evidence when accompanied by clinical features like abdominal obesity or elevated triglycerides.

Related Markers: Read Together for Full Context

BloodWorker reads lab values together, not in isolation. These related markers provide essential context for interpreting your Insulin result: